Form 8-K - Current report:
SEC Accession No. 0001493152-24-049385
Filing Date
2024-12-10
Accepted
2024-12-10 09:25:12
Documents
22
Period of Report
2024-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61680
2 ex4-1.htm EX-4.1 131442
3 ex4-2.htm EX-4.2 132163
4 ex4-3.htm EX-4.3 136573
5 ex5-1.htm EX-5.1 12136
6 ex10-1.htm EX-10.1 562166
7 ex10-2.htm EX-10.2 547769
8 ex99-1.htm EX-99.1 22270
9 ex99-1_001.jpg GRAPHIC 5037
10 ex99-1_002.jpg GRAPHIC 8722
  Complete submission text file 0001493152-24-049385.txt   2156391

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE sonn-20241209.xsd EX-101.SCH 3018
12 XBRL LABEL FILE sonn-20241209_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE sonn-20241209_pre.xml EX-101.PRE 24167
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3696
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 241537290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)